Loading...
XJPX6376
Market cap394mUSD
Jan 20, Last price  
964.00JPY
1D
-0.11%
1Q
-9.09%
Jan 2017
-16.29%
Name

Nikkiso Co Ltd

Chart & Performance

D1W1MN
XJPX:6376 chart
P/E
7.04
P/S
0.33
EPS
136.92
Div Yield, %
3.23%
Shrs. gr., 5y
-2.89%
Rev. gr., 5y
3.10%
Revenues
192.63b
+8.76%
54,307,000,00058,916,000,00065,399,000,00072,531,000,00072,395,000,00078,019,000,00083,143,000,00090,137,000,000103,670,000,000121,548,000,000129,255,000,000151,042,000,000132,890,000,000140,912,000,000165,326,000,000165,780,000,000158,542,000,000167,759,000,000177,109,000,000192,629,000,000
Net income
9.07b
-33.49%
2,518,000,0003,709,000,0004,015,000,0003,657,000,0001,367,000,0003,239,000,0002,684,000,0003,317,000,0006,897,000,0005,897,000,0005,099,000,0003,838,000,0002,729,000,0005,304,000,0007,595,000,0007,035,000,0006,560,000,000374,000,00013,639,000,0009,071,000,000
CFO
14.25b
+69.91%
5,206,000,0004,902,000,000937,000,0004,101,000,0004,409,000,00011,674,000,0006,004,000,0003,961,000,0008,398,000,0005,587,000,0008,183,000,0003,265,000,00012,608,000,0004,915,000,00014,076,000,00011,996,000,00012,480,000,0003,594,000,0008,384,000,00014,245,000,000
Dividend
Dec 27, 202415 JPY/sh
Earnings
Feb 14, 2025

Profile

Nikkiso Co., Ltd. engages in industrial, aerospace, precision equipment, deep ultraviolet-LEDs, and medical businesses worldwide. The company operates through Industrial Business and Medical Business segments. Its Industrial Business segment engages in manufacturing, sales, and maintenance of specialty industrial pumps, including non-leakage pumps; precision metering pumps; cryogenic pumps for pumping liquefied natural gas; industrial water conditioning systems for thermal and nuclear power plants, system products that combine water conditioning systems with automation and/or other functions, and warm laminating systems; other electronic component manufacturing equipment; and manufacturing and sales of carbon fiber reinforced plastic products for various civilian aircraft, and deep ultraviolet LEDs and related products. The company's Medical Business segment is involved in the manufacturing, sales, and maintenance of products and medical supplies for hemodialysis, peritoneal dialysis, and continuous renal replacement therapy, including dialysis systems, dialyzers, blood tubing lines, and powder-type dialysate; blood glucose controllers; air purification devices; ozone-water hand-washing systems; and microwave surgical instrument. The company was formerly known as Nippon Kikai Keiso Kaisha Ltd. and changed its name to Nikkiso Co., Ltd. in November 1968. Nikkiso Co., Ltd. was incorporated in 1950 and is headquartered in Tokyo, Japan.
IPO date
Oct 02, 1961
Employees
7,629
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122015‑03
Income
Revenues
192,629,000
8.76%
177,109,000
5.57%
Cost of revenue
190,799,000
188,011,000
Unusual Expense (Income)
NOPBT
1,830,000
(10,902,000)
NOPBT Margin
0.95%
Operating Taxes
2,488,000
18,835,000
Tax Rate
135.96%
NOPAT
(658,000)
(29,737,000)
Net income
9,071,000
-33.49%
13,639,000
3,546.79%
Dividends
(1,654,000)
(1,603,000)
Dividend yield
2.42%
2.41%
Proceeds from repurchase of equity
21,567,000
BB yield
-32.49%
Debt
Debt current
19,148,000
13,442,000
Long-term debt
78,170,000
91,204,000
Deferred revenue
4,000
4,216,000
Other long-term liabilities
3,854,000
97,000
Net debt
39,340,000
32,161,000
Cash flow
Cash from operating activities
14,245,000
8,384,000
CAPEX
(8,075,000)
(7,726,000)
Cash from investing activities
(9,225,000)
76,762,000
Cash from financing activities
(14,551,000)
(68,683,000)
FCF
(18,623,000)
(18,033,000)
Balance
Cash
32,304,000
48,805,000
Long term investments
25,674,000
23,680,000
Excess cash
48,346,550
63,629,550
Stockholders' equity
122,926,000
112,285,000
Invested Capital
162,846,450
144,234,450
ROIC
ROCE
0.86%
EV
Common stock shares outstanding
66,260
69,944
Price
1,030.00
8.54%
949.00
18.03%
Market cap
68,247,800
2.82%
66,376,856
15.73%
EV
109,449,800
100,074,856
EBITDA
12,281,000
(1,085,000)
EV/EBITDA
8.91
Interest
775,000
2,645,000
Interest/NOPBT
42.35%